Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT

Publisher： Karger

E-ISSN： 1421-9832|232|6|640-647

ISSN： 1018-8665

Source： Dermatology, Vol.232, Iss.6, 2017-01, pp. : 640-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Systemic Treatments for Moderate to Severe Plaque Psoriasis: Systematic Review and Meta-Analysis

By  

Dermatology, Vol. 219, Iss. 3, 2009-08 ,pp. : 209-218

Karger

Access to resources Recommend Favorite

Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry

By  

Dermatology, Vol. 232, Iss. 6, 2017-01 ,pp. : 655-663

Karger

Access to resources Recommend Favorite

PsoReg – The Swedish Registry for Systemic Psoriasis Treatment

By  

Dermatology, Vol. 214, Iss. 2, 2007-03 ,pp. : 112-117

Karger

Access to resources Recommend Favorite

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

By  

Dermatology, Vol. 232, Iss. 4, 2016-06 ,pp. : 385-406

Karger

Access to resources Recommend Favorite

Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 230, Iss. 1, 2015-01 ,pp. : 46-54

Karger

Access to resources Recommend Favorite